Putting cancer in context

June 04, 2002

Hanover, NH -- A Dartmouth Medical School/VA team has created simple risk charts to help people gauge the threat of cancer by presenting their chances of dying from various malignancies compared to other causes. Showing cancer in relation to other diseases provides context, which the DMS researchers say is necessary for individuals to assess how risks apply to them.

The charts appear in a report in the June 5 Journal of the National Cancer Institute by DMS and Veterans Affairs Outcomes Group physicians Steven Woloshin, Lisa Schwartz and H. Gilbert Welch.

People are regularly confronted with cancer risk information presented in ways that highlight the magnitude of the risk but provide little context. For example, "This year, approximately 182,800 women in the US will be diagnosed with invasive breast cancer, and approximately 40,800 women will die from breast cancer." Without context, such messages may lead people to overestimate the risks they face. In the example above, if you are a 40 year-old woman who has never smoked, your chance of dying from breast cancer in the next ten years is 0.2 percent and stays below one percent until the age of 70.

The charts are designed to be simple, low-tech tools that can be used anywhere. They put cancer in context by placing the 10-year chance of dying from various causes side by side. To facilitate their use in a clinical setting, the risk charts include data for a range of ages on a single page. There are separate charts for male and female smokers and never smokers.

Woloshin said, "We believe that our risk charts will help people better understand and compare the important health threats they face. The charts could be posted in clinic offices or distributed to patients for easy reference when decisions are made. Because the charts give people a sense of how much smoking adds to their chance of dying at every age, they may also be useful in smoking prevention and cessation efforts."

The Dartmouth team used the Multiple Cause of Death File from the National Center for Health Statistics and population estimates from the US Census to calculate death rates for heart disease, stroke, lung, colon, breast and prostate cancer, AIDS, pneumonia, influenza, and accidents, as well as death rates from all causes. They then calculated the 10-year chance of dying for each cause for men and women in 5-year age intervals from age 20 to age 90 and estimated these chances for current smokers and for never smokers.

The researchers caution that the charts only present data about mortality, not disease incidence. Judgments about incidence are far more ambiguous than those about death. Also, risk estimates are not completely individualized. Patients with important disease risk factors, such as a family history of a disease, might obtain more precise estimates of risk from that disease with a customized assessment. The team did, however, account for what are arguably the most important risk factors for death: age, sex and smoking.
Woloshin and Schwartz are also affiliated with Dartmouth's Norris Cotton Cancer Center. For more information, contact Lisa Schwartz, MD, at lisa.schwartz@dartmouth.edu.

DMS news is on the web at www.dartmouth.edu/dms/news.

The Geisel School of Medicine at Dartmouth

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.